PainReform Ltd., trading under the ticker NASDAQ:PRFX, witnessed a marked rise in its share price during the premarket trading session, climbing 27.4% to a price of $1.02 per share. This price movement comes on the heels of the company’s announcement regarding a name change, which reflects its strategic expansion into sectors encompassing diversified healthcare services as well as artificial intelligence-driven energy platforms, underscoring shifts in business focus aimed at tapping into emerging market opportunities.
Premarket trading often provides insight into the market's early response to company news and sector trends. Today, alongside PainReform Ltd., several other stocks displayed noteworthy premarket activity. Acco Group Holdings Limited (NASDAQ:ACCL) led the day’s gainers, skyrocketing by 219.4% to $9.40. This represents a significant premarket surge following its previous close, indicating strong investor interest and sentiment towards the company’s prospects.
Venus Concept Inc. (NASDAQ:VERO) also demonstrated robust premarket gains, increasing 72.2% to $2.48. Similarly, Jaguar Health, Inc. (NASDAQ:JAGX) advanced by 41.3% to $1.08, buoyed by news of its licensing agreement with Woodward Specialty, signaling expansion in their operational footprint.
Investors showed increased enthusiasm in ImmunityBio, Inc. (NASDAQ:IBRX), which climbed 22.8% to $4.85 following a strong performance on Thursday where shares jumped over 30%. The gain aligns with their report projecting preliminary net product revenue for their Anktiva product at approximately $113 million for fiscal 2025, representing a significant 700% year-over-year increase. This notable growth figure may be influencing investor confidence in the company’s financial outlook and product trajectory.
Other stocks demonstrating positive premarket movement included OneMedNet Corporation (NASDAQ:ONMD), up 14.2% to $0.97 after a substantial drop the prior day, and Brand Engagement Network, Inc. (NASDAQ:BNAI), which grew by 13.8% to $6.50. Springview Holdings Ltd (NASDAQ:SPHL) increased 13.4% to $19.75 following an extraordinary 657% advance on Thursday, indicating sustained momentum. Creative Global Technology Holdings Limited (NASDAQ:CGTL) also moved higher by 10.7% to $4.22 after a previous jump of 52%. Additional gains were observed with Kopin Corporation (NASDAQ:KOPN), which gained 8.1% reaching $3.20.
Conversely, several stocks declined in premarket trading. Callan JMB Inc. (NASDAQ:CJMB) experienced the steepest drop among the laggards, sliding 20.7% to $3.33, despite a significant 275% gain on Thursday spurred by a strategic teaming agreement with Biostax Corp operating as Attune Biotech to provide comprehensive federal oversight services.
Erayak Power Solution Group Inc. (NASDAQ:RAYA) retraced 18.3% to $3.21 after an 18% rise on Thursday. TryHard Holdings Limited (NASDAQ:THH) declined 16.4% to $6.35, continuing a downward trend that included a 76% dip the previous day, influenced by the announcement of a Memorandum of Cooperation with STAR PARTY HK LIMITED to explore a joint venture in Japan, which may be eliciting mixed investor reactions.
Other notable decliners included iOThree Limited (NASDAQ:IOTR), which dropped 15% to $2.56; NOVONIX Limited (NASDAQ:NVX), down 14% to $1.17; and Moolec Science SA (NASDAQ:MLEC), down 13.1% to $6.69 after a 118% increase on Thursday. High Roller Technologies, Inc. (NYSE:ROLR) slipped 12.9% to $20.64, following a 25% gain prompted by the announcement of a non-binding Letter of Intent with Lines.com.
Additional losses were seen in Bonk, Inc. (NASDAQ:BNKK), which declined 10.4% to $3.55 after a previous gain exceeding 42% linked to its acquisition announcement by the TSX Venture Exchange. J B Hunt Transport Services Inc (NASDAQ:JBHT) fell 4.2% to $197.86 amid mixed financial results for the fourth quarter. Lastly, QXO Inc (NYSE:QXO) dipped 3.5% to $24.14 after unveiling a $750 million common stock offering alongside preliminary fourth-quarter net sales of $2.19 billion.
The premarket price fluctuations observed across these companies reflect a mix of strategic developments, revenue outlooks, and investor sentiment adjusting to recent corporate announcements. PainReform Ltd.’s decision to rebrand and pursue diversified healthcare and AI-centric energy ventures appears to have resonated positively with investors in the early trading hours, mirroring heightened expectations for the company's direction.